These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 2968273

  • 1. Different roles of D-1 and D-2 dopamine receptors involved in locomotor activity of supersensitive mice.
    Rubinstein M, Gershanik O, Stefano FJ.
    Eur J Pharmacol; 1988 Apr 13; 148(3):419-26. PubMed ID: 2968273
    [Abstract] [Full Text] [Related]

  • 2. Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice.
    Rubinstein M, Schinder AF, Gershanik O, Stefano FJ.
    Life Sci; 1989 Apr 13; 44(5):337-46. PubMed ID: 2536881
    [Abstract] [Full Text] [Related]

  • 3. Behavioural synergism between the dopamine agonists SKF 38393 and LY 171555 in dopamine-depleted mice: antagonism by sulpiride reveals only stimulant postsynaptic D-2 receptors.
    Starr MS, Starr BS.
    Pharmacol Biochem Behav; 1989 May 13; 33(1):41-4. PubMed ID: 2571171
    [Abstract] [Full Text] [Related]

  • 4. Role of D-1 and D-2 receptors in apomorphine-induced pecking in chicks.
    Zarrindast MR, Amin R.
    Psychopharmacology (Berl); 1992 May 13; 106(1):67-70. PubMed ID: 1346722
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of dopamine agonists on locomotion in intact and reserpine-treated mice.
    Zarrindast MR, Eliassi A.
    Gen Pharmacol; 1991 May 13; 22(6):1027-31. PubMed ID: 1687393
    [Abstract] [Full Text] [Related]

  • 6. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ.
    Pharmacol Biochem Behav; 1988 May 13; 30(1):189-93. PubMed ID: 2902644
    [Abstract] [Full Text] [Related]

  • 7. Lesions of the nigrostriatal dopamine projection increase the inhibitory effects of D1 and D2 dopamine agonists on caudate-putamen neurons and relieve D2 receptors from the necessity of D1 receptor stimulation.
    Hu XT, Wachtel SR, Galloway MP, White FJ.
    J Neurosci; 1990 Jul 13; 10(7):2318-29. PubMed ID: 1973947
    [Abstract] [Full Text] [Related]

  • 8. Involvement of dopaminergic receptor subtypes in straub tail behaviour in mice.
    Zarrindast MR, Bayat A, Shafaghi B.
    Gen Pharmacol; 1993 Jan 13; 24(1):127-30. PubMed ID: 8097737
    [Abstract] [Full Text] [Related]

  • 9. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J.
    Eur J Pharmacol; 1985 Jul 11; 113(1):79-88. PubMed ID: 2931283
    [Abstract] [Full Text] [Related]

  • 10. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T, Sharp T, Ungerstedt U.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct 11; 334(2):117-24. PubMed ID: 2946964
    [Abstract] [Full Text] [Related]

  • 11. Effects of acute dopamine depletion on responsiveness to D1 and D2 receptor agonists in infant and weanling rat pups.
    Moody CA, Spear LP.
    Psychopharmacology (Berl); 1992 Oct 11; 107(1):39-49. PubMed ID: 1350350
    [Abstract] [Full Text] [Related]

  • 12. Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?
    Jackson DM, Mohell N, Bengtsson A, Malmberg A.
    Eur J Pharmacol; 1995 Aug 25; 282(1-3):137-44. PubMed ID: 7498268
    [Abstract] [Full Text] [Related]

  • 13. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G, Collu M, D'Aquila PS, De Montis GM, Gessa GL.
    Brain Res; 1990 Sep 17; 527(2):234-43. PubMed ID: 1979237
    [Abstract] [Full Text] [Related]

  • 14. The involvement of dopamine D1 and D2 receptors in the locomotor stimulation produced by (+)-amphetamine in naive and dopamine-depleted mice.
    Ross SB, Jackson DM, Edwards SR.
    Pharmacol Toxicol; 1989 Jan 17; 64(1):72-7. PubMed ID: 2526949
    [Abstract] [Full Text] [Related]

  • 15. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR, Mueller RA.
    Eur J Pharmacol; 1985 Jul 11; 113(1):109-14. PubMed ID: 2864260
    [Abstract] [Full Text] [Related]

  • 16. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse.
    Ross SB, Jackson DM, Wallis EM, Edwards SR.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May 11; 337(5):512-8. PubMed ID: 3261844
    [Abstract] [Full Text] [Related]

  • 17. Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice.
    Zarrindast MR, Minaian A.
    Gen Pharmacol; 1991 May 11; 22(6):1017-21. PubMed ID: 1687391
    [Abstract] [Full Text] [Related]

  • 18. Involvement of dopamine receptor subtypes in mouse thermoregulation.
    Zarrindast MR, Tabatabai SA.
    Psychopharmacology (Berl); 1992 May 11; 107(2-3):341-6. PubMed ID: 1535446
    [Abstract] [Full Text] [Related]

  • 19. Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.
    Longoni R, Spina L, Di Chiara G.
    Eur J Pharmacol; 1987 Feb 10; 134(2):163-73. PubMed ID: 2883010
    [Abstract] [Full Text] [Related]

  • 20. Permissive role of D-1 receptor stimulation for the expression of D-2 mediated behavioral responses: a quantitative phenomenological study in rats.
    Longoni R, Spina L, Di Chiara G.
    Life Sci; 1987 Nov 02; 41(18):2135-45. PubMed ID: 2959833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.